Showing 44,661 - 44,680 results of 46,288 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.51s Refine Results
  1. 44661

    Image1_Effects of Temperature and Additives on NOx Emission From Combustion of Fast-Growing Grass.PNG by Haili Liu (395833)

    Published 2021
    “…At combustion temperatures of 600, 700, 750, 800, and 850°C, the optimal conditions to limit NO<sub>x</sub> emissions were 5% SiO<sub>2</sub>, 3% Al<sub>2</sub>O<sub>3</sub>, 3% Ca(OH)<sub>2</sub>, 15% Al<sub>2</sub>O<sub>3</sub>, and 3% SiO<sub>2</sub> (or 3% Al<sub>2</sub>O<sub>3</sub>), respectively; the corresponding emission peaks decreased by 43.59, 44.21, 47.99, 24.18, and 30.60% (or 31.51%), with denitration rates of 63.28, 50.34, 57.44, 27.05, and 27.34% (or 27.28%), respectively.…”
  2. 44662

    DataSheet1_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

    Published 2022
    “…The rats were intragastrically administered with 50% CCl<sub>4</sub> for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”
  3. 44663
  4. 44664

    Urine Bacterial Community Convergence through Fertilizer Production: Storage, Pasteurization, and Struvite Precipitation by Rebecca H. Lahr (3217476)

    Published 2016
    “…Urine pasteurization or struvite precipitation did not change the microbial community, even when pasteurized urine was stored for an additional 70 days. Pasteurization decreased metabolic activity by 50 ± 10% and additional storage after pasteurization did not lead to recovery of metabolic activity. …”
  5. 44665

    DataSheet2_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

    Published 2022
    “…The rats were intragastrically administered with 50% CCl<sub>4</sub> for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”
  6. 44666

    STAT3 represses Jmjd3 expression in glioblastoma stem cells. by Maureen M. Sherry-Lynes (3911521)

    Published 2017
    “…E. S3I-201 treatment decreases NCor binding at the Jmjd3 promoter. GS6-22 cells were treated with S3I-201 (50 μM) or DMSO for 4 hours, fixed, lysed, and sonicated. …”
  7. 44667

    Data_Sheet_1_Unraveling shared susceptibility loci and Mendelian genetic associations linking educational attainment with multiple neuropsychiatric disorders.docx by Dongze Chen (12283640)

    Published 2024
    “…MR confirmed higher genetically predicted EA lower the risk of ADHD (OR<sub>IVW</sub>: 0.50; 95% CI: 0.39 to 0.63) and genetically predicted ADHD decreased the risk of EA (Causal effect: −2.8 months; 95% CI: −3.9 to −1.8).…”
  8. 44668

    Table_1_Genetic polymorphisms in CYP4F2 may be associated with lung cancer risk among females and no-smoking Chinese population.docx by Hongyang Shi (836187)

    Published 2023
    “…</p>Results<p>This study observed that rs12459936 was linked to an increased risk of LC in no-smoking participants (allele: OR = 1.38, p = 0.035; homozygote: OR = 2.00, p = 0.035; additive: OR = 1.40, p = 0.034) and females (allele: OR = 1.64, p = 0.002; homozygote: OR = 2.57, p = 0.006; heterozygous: OR = 2.56, p = 0.001; dominant: OR = 2.56, p < 0.002; additive: OR = 1.67, p = 0.002). Adversely, there was a significantly decreased LC risk for rs3093110 in no-smoking participants (heterozygous: OR = 0.56, p = 0.027; dominant: OR = 0.58, p = 0.035), rs3093193 (allele: OR = 0.66, p = 0.016; homozygote: OR = 0.33, p = 0.011; recessive: OR = 0.38, p = 0.021; additive: OR = 0.64, p = 0.014), rs3093144 (recessive: OR = 0.20, p = 0.045), and rs3093110 (allele: OR = 0.54, p = 0.010; heterozygous: OR = 0.50, p = 0.014; dominant: OR = 0.49, p = 0.010; additive: OR = 0.54, p = 0.011) in females.…”
  9. 44669

    Down-regulation astrocyte-derived NT-3 <i>in vivo</i> reversed the trace fear memory of <i>Fmr1</i> KO mice. by Qi Yang (108283)

    Published 2012
    “…<p>A, ACC section (left upper) showing bilateral GFP-expressing astrocytes 10 days after microinjection. …”
  10. 44670

    Image1_Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.TIF by Derrick Crawford (12414670)

    Published 2022
    “…Molar but not incisor tooth movement was inhibited over 50% by injection of the NO releasing nanoparticles. …”
  11. 44671

    Enhanced cell death in Ku70 KD cells is caspase-dependent. by Mohamed K. Hassan (550762)

    Published 2014
    “…<p><b><i>A</i></b>. Ku70 KD and control PC-10 cells were treated with hyperthermia (42.5°C) for 6 h in presence or absence of caspase inhibitor (Z-VAD; 50 nM). …”
  12. 44672

    Effects of Dp on mitochondrial dysfunction in oxLDL-induced HUVECs. by Xin Jin (108988)

    Published 2013
    “…(A) Intracellular ROS levels were estimated using the probe DCFH-DA. …”
  13. 44673

    GWAS analysis to assess TPC2 SNP disease association. by Julia Böck (397145)

    Published 2021
    “…(H) We further investigated the association between V219I and other SNPs. We found V219I and M484L SNPs to be linked, with less linkage between M484L and other SNPs. …”
  14. 44674

    Data_Sheet_1_Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.docx by Shiyue Qin (11870957)

    Published 2021
    “…</p><p>Methods: Twenty-five eyes in 18 treatment-naïve patients with DME were included. …”
  15. 44675

    Image2_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

    Published 2022
    “…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”
  16. 44676

    Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  17. 44677

    Image_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  18. 44678

    Image_1_Physical Responses of Pinctada fucata to Salinity Stress.TIF by Jingru Yang (2626306)

    Published 2022
    “…In this study, the salinity of 35‰ was used as the control, while the salinities of 20 and 50% salinity were used as the low and high salt treatment groups, respectively. …”
  19. 44679

    Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”
  20. 44680

    Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”